Revising the role and transparency of notified bodies in the EU’s medical device approval process could be the centerpiece of the European Commission’s September recast of the Medical Device Directive (MDD). The upcoming revision will significantly strengthen how notified bodies function and are designated, commission spokesman Frédéric Vincent told
IMDRM.
International Medical Device Regulatory Monitor